This is the second time the company has passed the authoritative certification after its first recognition as a high-tech enterprise in 2022, marking that the company's comprehensive strength in technological innovation, R&D investment, and transformation of scientific and technological achievements has been continuously recognized at the national level.

Since its establishment, the company has always adhered to the innovation-driven development strategy, focused on the core fields of biotechnology, continuously improved its R&D system and intellectual property layout, and achieved remarkable results in key technological breakthroughs and industrial application.

The renewal of this qualification will further help the company optimize resource allocation and enhance market competitiveness. In the future, the company will continue to deepen its efforts in the field of biotechnology, strengthen technological innovation and achievement transformation, and contribute greater value to industry development and regional economy.